Cytokines and Uremic Toxins

Cytokines and uremic toxins represent a heterogeneous group of molecules that accumulate in the blood due to impaired renal clearance or systemic inflammatory states. Cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), are signaling proteins that regulate immune responses but contribute to chronic inflammation and organ damage when persistently elevated (Ankawi et al., 2019, PubMed). Uremic toxins are metabolic byproducts classified into small water-soluble compounds (e.g., urea), protein-bound solutes (e.g., indoxyl sulfate), and middle molecules (e.g., beta-2 microglobulin) (Vanholder et al., 2003, Lancet). These substances exert multi-organ toxicity, particularly affecting the cardiovascular, neurological, and immune systems in patients with chronic kidney disease (Duranton et al., 2012, JASN). Therapeutic interventions focus on the physical removal of these molecules through hemodialysis, hemodiafiltration, or hemoperfusion using specialized adsorbent polymers like CytoSorb. Additionally, oral adsorbents like AST-120 are used to sequester toxin precursors in the gut to reduce systemic burden. Because this entry describes a broad category of hundreds of chemically distinct entities rather than a single molecular target, it is considered a collective therapeutic objective in renal and critical care medicine.

Other names

Uremic retention solutesInflammatory mediatorsMiddle moleculesProtein-bound uremic toxinsUremic metabolites

Extracorporeal removal via adsorption, diffusion, and convection; pharmacological neutralization of specific inflammatory mediators; oral adsorption to prevent gastrointestinal absorption.